Harvey Jimmie H JH

OmicsDI

Browse
Submit Data
Databases
API

1 Result

Show all Save search Copy query

Show results for

Unknown (1)

Publication Date

Release Date

2013 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

10

Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.

Purpose

To assess the effects of ruxolitinib on symptom burden and quality of life (QoL) and to evaluate the ability of the modified Myelofibrosis Symptom Assessment Form (MFSAF) v2.0 to measure meaningful changes in myelofibrosis-related symptoms in patients with myelofibrosis.